These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29351801)

  • 21. The role of SOX18 in bladder cancer and its underlying mechanism in mediating cellular functions.
    Huaqi Y; Caipeng Q; Qiang W; Yiqing D; Tao X
    Life Sci; 2019 Sep; 232():116614. PubMed ID: 31260682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer.
    He A; Liu Y; Chen Z; Li J; Chen M; Liu L; Liao X; Lv Z; Zhan Y; Zhuang C; Lin J; Huang W; Mei H
    J Exp Clin Cancer Res; 2016 Aug; 35(1):125. PubMed ID: 27514530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer.
    Li Z; Lin C; Zhao L; Zhou L; Pan X; Quan J; Peng X; Li W; Li H; Xu J; Xu W; Guan X; Chen Y; Lai Y
    Biomed Pharmacother; 2018 Sep; 105():461-469. PubMed ID: 29883941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis.
    Wang C; Ge Q; Zhang Q; Chen Z; Hu J; Li F; Ye Z
    J Exp Clin Cancer Res; 2016 Mar; 35():53. PubMed ID: 27012825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of MELK produces potential anti-tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathway.
    Chen S; Zhou Q; Guo Z; Wang Y; Wang L; Liu X; Lu M; Ju L; Xiao Y; Wang X
    J Cell Mol Med; 2020 Jan; 24(2):1804-1821. PubMed ID: 31821699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoting roles of long non-coding RNA FAM83H-AS1 in bladder cancer growth, metastasis, and angiogenesis through the c-Myc-mediated ULK3 upregulation.
    Liu B; Gao W; Sun W; Li L; Wang C; Yang X; Liu J; Guo Y
    Cell Cycle; 2020 Dec; 19(24):3546-3562. PubMed ID: 33289601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HYOU1 promotes cell proliferation, migration, and invasion via the PI3K/AKT/FOXO1 feedback loop in bladder cancer.
    Wang W; Jiang X; Xia F; Chen X; Li G; Liu L; Xu Q; Zhu M; Chen C
    Mol Biol Rep; 2023 Jan; 50(1):453-464. PubMed ID: 36348197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
    Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W
    J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of Long Noncoding RNA LUCAT1 Suppresses the Migration and Invasion of Bladder Cancer by Targeting miR-181c-5p.
    Chen Y; Zhang W; Shen L; Kadier A; Huang J; Wang R; Wu P; Yao X
    Biomed Res Int; 2020; 2020():4817608. PubMed ID: 33282949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion.
    Zhang C; Wang W; Lin J; Xiao J; Tian Y
    Int Braz J Urol; 2019; 45(3):549-559. PubMed ID: 31038865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
    Wang JR; Liu B; Zhou L; Huang YX
    Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.
    Wang FH; Ma XJ; Xu D; Luo J
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bladder Cancer Progression Is Suppressed Through the Heart and Neural Crest Derivatives Expressed 2-Antisense RNA 1/microRNA-93-5p/Defective in Cullin Neddylation 1 Domain Containing 3 Axis.
    Wu X; Xu Q; Li T; Wei Y; Zeng R; Lin R; Xu L; Ye L; Liu Z
    Appl Biochem Biotechnol; 2023 Jul; 195(7):4116-4133. PubMed ID: 36656536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.
    Zhou X; Zhang P; Han H; Lei H; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6471-6481. PubMed ID: 30417565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DHCR7 promotes tumorigenesis via activating PI3K/AKT/mTOR signalling pathway in bladder cancer.
    Li Y; Zhou Y; Huang M; Wang Z; Liu D; Liu J; Fu X; Yang S; Shan S; Yang L; Guo Y; Ren P; Chen P; Zeng G; Guo Y; Wang X; DiSanto ME; Zhang X
    Cell Signal; 2023 Feb; 102():110553. PubMed ID: 36473621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of NDRG1 predicts poor outcome and facilitates disease progression by influencing the EMT process in bladder cancer.
    Li A; Zhu X; Wang C; Yang S; Qiao Y; Qiao R; Zhang J
    Sci Rep; 2019 Mar; 9(1):5166. PubMed ID: 30914736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FAM107A as a Tumor Suppressor in Bladder Cancer Inhibits Cell Proliferation, Migration, and Invasion.
    Ou L; Wei Z; Xu J; Li W; Zhou Y; Wang Y; Shi B
    Ann Clin Lab Sci; 2022 Mar; 52(2):260-268. PubMed ID: 35414505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AEBP1 Contributes to Breast Cancer Progression by Facilitating Cell Proliferation, Migration, Invasion, and Blocking Apoptosis.
    Li J; Ruan Y; Zheng C; Pan Y; Lin B; Chen Q; Zheng Z
    Discov Med; 2023 Feb; 35(174):45-56. PubMed ID: 37024441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circular RNA circFLNA inhibits the development of bladder carcinoma through microRNA miR-216a-3p/BTG2 axis.
    Lin S; Wang L; Shi Z; Zhu A; Zhang G; Hong Z; Cheng C
    Bioengineered; 2021 Dec; 12(2):11376-11389. PubMed ID: 34852712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Centromere protein U is a potential target for gene therapy of human bladder cancer.
    Wang S; Liu B; Zhang J; Sun W; Dai C; Sun W; Li Q
    Oncol Rep; 2017 Aug; 38(2):735-744. PubMed ID: 28677729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.